Tourette’s syndrome
FDA approves Alvotech and Teva’s Simlandi as interchangeable Humira biosimilar
Simlandi is approved to treat multiple indications, including rheumatoid arthritis and Crohn’s disease
Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined
Nearly 500,000 died from an opioid overdose between 1999 and 2019
Teva reaches $925,000 settlement to resolve drug price-fixing claims
Last year, the US Department of Justice charged Teva for conspiring with competitors in a generic drug price-fixing probe
Pfizer, Sanofi and others set to increase US drug prices in 2021
Pressure from COVID-19 restrictions leads to drug price increases
US charges Teva for generic drug price-fixing plot
Company maintains it has not committed any wrongdoing
US states sue generic firms over ‘inflated’ prices
Companies accused of “multi-billion dollar fraud" and conspiracy
Teva will have to endure revenue ‘trough’ in 2019
Company looks to migrane treatment Ajovy for growth
Teva wins FDA OK for crucial migraine drug
Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig
Daily Brief: Biosimilar Herceptin can’t make Perjeta cost effective and more
E-cigarettes can save lives - Teva gains approval for EpiPen generic